Published in
Springer, Rheumatology and Therapy, 1(8), p. 199-217, 2020
DOI: 10.1007/s40744-020-00261-0
Links
Tools
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)
Journal article published in 2020 by
Ana-Maria Orbai 
,
Jordi Gratacós ,
Anthony Turkiewicz,
Stephen Hall,
Eva Dokoupilova,
Bernard Combe,
Peter Nash,
Gaia Gallo,
Clinton C. Bertram,
Amanda M. Gellett,
Aubrey Trevelin Sprabery,
Julie Birt,
Lisa Macpherson,
Vladimir J. Geneus,
Arnaud Constantin
,
Jordi Gratacós ,
Anthony Turkiewicz,
Stephen Hall,
Eva Dokoupilova,
Bernard Combe,
Peter Nash,
Gaia Gallo,
Clinton C. Bertram,
Amanda M. Gellett,
Aubrey Trevelin Sprabery,
Julie Birt,
Lisa Macpherson,
Vladimir J. Geneus,
Arnaud Constantin
This paper is made freely available by the publisher.
Full text: Download
Data provided by 